Press Releases

Press Releases

Filters
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
Viatris to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors
Viatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference
Viatris Announces Donations Totaling $1 Million to Provide Aid Supporting Access to Healthcare, Food Security and Water Stewardship
Viatris Announces Approval of Emissions Reduction Targets by the Science Based Target initiative (SBTi)
Viatris Completes Biosimilars Transaction with Biocon Biologics
Viatris Named U.S. In-House Legal Team of the Year for Intellectual Property Litigation by LMG Life Sciences
Displaying 71 - 80 of 137